Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective laser trabeculoplasty: a review.

Tony Realini1

  • 1Department of Ophthalmology, West Virginia University, Morgantown, WV 26505, USA. realinia@wvuh.com

Journal of Glaucoma
|September 17, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eyes of Africa: The Genetics of Blindness. Baseline characteristics, ocular features, and associations with glaucoma in continental Africans.

Eye (London, England)·2026
Same author

Design and Baseline Characteristics of Participants in the Clarifying the Optimal Application of Selective Laser Trabeculoplasty (SLT) Therapy (COAST) Trial 1.

Journal of glaucoma·2026
Same author

Selective Laser Trabeculoplasty and the Evolving Glaucoma Paradigm.

Ophthalmology. Glaucoma·2025
Same author

Patients' Acceptance of Glaucoma Therapy in Sub-Saharan Africa.

Journal of glaucoma·2024
Same author

Test-Retest Reliability of Intraocular Pressure Measurements With Office-Based Versus Home-Based Rebound Tonometers.

Journal of glaucoma·2024
Same author

Glaucoma Treatment Patterns in Sub-Saharan Africa.

Journal of glaucoma·2023

Selective laser trabeculoplasty (SLT) offers effective intraocular pressure (IOP) reduction for glaucoma, matching argon laser trabeculoplasty and medical treatments. It presents a safe option for primary or adjunctive glaucoma therapy.

Area of Science:

  • Ophthalmology
  • Glaucoma treatment
  • Laser therapy

Background:

  • Selective laser trabeculoplasty (SLT) has increased interest in laser procedures for glaucoma.
  • Glaucoma management often involves reducing intraocular pressure (IOP).

Purpose of the Study:

  • To review clinical practice issues related to SLT.
  • To evaluate SLT's efficacy and safety compared to other glaucoma treatments.

Main Methods:

  • Review of peer-reviewed medical literature on SLT.
  • Comparison of SLT with argon laser trabeculoplasty and topical medical therapy.

Main Results:

  • SLT shows equivalent efficacy and safety to argon laser trabeculoplasty.
  • SLT is as effective as topical medical therapy for IOP reduction.

Related Experiment Videos

  • SLT has a favorable safety profile with mild, transient side effects.

    • Conclusions:

    • SLT is a safe and effective treatment for lowering IOP in glaucoma patients.
    • SLT can be utilized as either a primary or adjunctive therapy for glaucoma.